Vnitr Lek 1989, 35(12):1183-1189

[Thyroid gland function after short-term administration of amiodarone and digoxin].

B Renker, E Augustín, J Vavrík, A Lehotská, M Hajduchová

The authors administered to 13 patients with auricular fibrillation amiodarone (Cordarone), 1200 mg/day, by the oral route from the 4th to the 10th day of the trial, 600 mg per day from the 11th to the 13th day of the trial. Simultaneously the patients were given digoxin, 1 mg, by the i.v. route: on the first day 1 mg i.v., 2nd to 5th day 0.5 mg i.v., and on the 6th to 10th day of the trial 0.25 mg. They assessed the serum digoxin concentration on the 1st, 4th, 11th and 14th day, the serum concentration of triiodothyronine (T3), thyroxine (T4) and thyrotropic hormone (TSH) on the 1st and 14th day of the trial. The authors revealed that after ten days administration of amiodarone T4 does not change (102.4 +/- 28.2 nmol/l vs. 101.3 +/- 13.4 nmol/l, NS), T3 declines significantly (2.47 +/- 0.85 nmol/l vs. 1.86 +/- 0.54 nmol/l, p less than 0.001) and TSH rises insignificantly (2.82 +/- 1.18 mU/l vs. 3.34 +/- 1.43, NS). Consistent with data in the literature on the effect of several weeks administration of amiodarone on thyroid function, the authors assume inhibition of 5'monodeiodization of T4 with a reduced formation of T3 and increased formation of rT3. The drop of T3 may play a part also in the antiarrhythmic action of amiodarone in the treatment of auricular fibrillation.

Keywords: Aged; Amiodarone, pharmacology, ; Digoxin, pharmacology, ; Female; Humans; Male; Thyroid Gland, drug effects, ; Thyroid Hormones, metabolism,

Published: December 1, 1989  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Renker B, Augustín E, Vavrík J, Lehotská A, Hajduchová M. [Thyroid gland function after short-term administration of amiodarone and digoxin]. Vnitr Lek. 1989;35(12):1183-1189.
Download citation




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.